AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 25623934 — intervention group
Group type: EXPERIMENTAL
Intervention: Tramadol 50mg
Number of subjects: 30
Study 25623934 — intervention group
Group type: COMPARATOR
Intervention: 5% Ringer's lactate 1ml (Control)
Number of subjects: 30
Study 22935323 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM-EC group (received counseling for both LAM and EC with in-advance provision of one packet of EC pills)
Number of subjects: 1158
Study 22935323 — intervention group
Group type: COMPARATOR
Intervention: LAM-only group (received proper LAM counseling without EC counseling)
Number of subjects: 1158
Study 22935323 — intervention group
Group type: COMPARATOR
Intervention: LAM-only group
Number of subjects: 1158
Study 22935323 — intervention group
Group type: EXPERIMENTAL
Intervention: LAM-EC group
Number of subjects: 1158
Study 20939928 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient navigation and activation intervention
Number of subjects: 344
Study 20939928 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 344
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Citalopram (Level 1)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to sustained-release bupropion (Level 2)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to sertraline (Level 2)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Switch to extended-release venlafaxine (Level 2)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue citalopram and receive augmentation with sustained-release bupropion (Level 2)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Continue citalopram and receive augmentation with buspirone (Level 2)
Number of subjects: 2876
Study 18172020 — intervention group
Group type: EXPERIMENTAL
Intervention: Anxious depression group (Level 1 and Level 2)
Number of subjects: 2876
Study 17010756 — intervention group
Group type: EXPERIMENTAL
Intervention: 16-week cyclosporin A (CsA)
Number of subjects: 99
Study 17010756 — intervention group
Group type: EXPERIMENTAL
Intervention: 8-week cyclosporin A (CsA) + 8-week placebo
Number of subjects: 99
Study 17010756 — intervention group
Group type: COMPARATOR
Intervention: 16-week placebo
Number of subjects: 99
Study 14689413 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-lumen endotracheal tube
Number of subjects: 32
Study 14689413 — intervention group
Group type: COMPARATOR
Intervention: Single-lumen tube with bronchial blocker
Number of subjects: 32
Study 10983674 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose GIK therapy (insulin solution 225 IU, glucose, potassium, and mixed amino acids 11.4 g)
Number of subjects: 33
Study 10983674 — intervention group
Group type: COMPARATOR
Intervention: Control group (mixed amino acids 11.4 g)
Number of subjects: 33
Study 8959306 — intervention group
Group type: EXPERIMENTAL
Intervention: Telethermography (TTG) scans
Number of subjects: 14
Study 1543675 — intervention group
Group type: EXPERIMENTAL
Intervention: 1% terbinafine cream
Number of subjects: 33
Study 1543675 — intervention group
Group type: COMPARATOR
Intervention: 0.1% gentamicin sulphate cream
Number of subjects: 33
Study 4024909 — intervention group
Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (one patch)
Number of subjects: 16
Study 4024909 — intervention group
Group type: EXPERIMENTAL
Intervention: TTS‐scopolamine (two patches)
Number of subjects: 16
Study 4024909 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimenhydrinate (100 mg)
Number of subjects: 16
Study 4024909 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31881049 — intervention group
Group type: EXPERIMENTAL
Intervention: Secondary schooling
Number of subjects: 49
Study 29808331 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical chamomile oleogel
Number of subjects: 100
Study 29808331 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 26848258 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 mg/day conivaptan
Number of subjects: 251
Study 26848258 — intervention group
Group type: EXPERIMENTAL
Intervention: 40 mg/day conivaptan
Number of subjects: 251
Study 25340768 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthy Nordic diet (ND) rich in whole grain rye and wheat, berries, fruits and vegetables, rapeseed oil, three fish meals per week, and low-fat dairy products for 18/24 weeks.
Number of subjects: 158
Study 25340768 — intervention group
Group type: COMPARATOR
Intervention: Control diet for 18/24 weeks.
Number of subjects: 158
Study 22788574 — intervention group
Group type: EXPERIMENTAL
Intervention: Moleca® shoes for six months for at least six hours daily
Number of subjects: 56
Study 22788574 — intervention group
Group type: COMPARATOR
Intervention: Control group (no use of Moleca® shoes)
Number of subjects: 56
Study 19280085 — intervention group
Group type: EXPERIMENTAL
Intervention: Impella LP2.5 percutaneous left ventricular support
Number of subjects: 6
Study 19280085 — intervention group
Group type: COMPARATOR
Intervention: No support (control group)
Number of subjects: 6
Study 17297176 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA‐C
Number of subjects: 400
Study 17297176 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo cream)
Number of subjects: 400
Study 17297176 — intervention group
Group type: EXPERIMENTAL
Intervention: EMLA‐C (1-2 hours application)
Number of subjects: 400
Study 14985870 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone scintigraphy evaluated by the new method of determining total or partial involvement of individual vertebrae
Number of subjects: 84
Study 14985870 — intervention group
Group type: COMPARATOR
Intervention: Bone scintigraphy evaluated by the conventional Soloway grading
Number of subjects: 84
Study 11600329 — intervention group
Group type: EXPERIMENTAL
Intervention: RAMP waveform (ramp onset and ramp offset)
Number of subjects: 8
Study 11600329 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramp-to-Parabola (R-P) waveform (ramp onset with parabolic offset)
Number of subjects: 8
Study 11600329 — intervention group
Group type: EXPERIMENTAL
Intervention: SINE waveform (sine-wave onset with sine wave offset)
Number of subjects: 8
Study 9673473 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% apraclonidine
Number of subjects: 54
Study 9673473 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.25% apraclonidine
Number of subjects: 54
Study 9673473 — intervention group
Group type: COMPARATOR
Intervention: Artificial tears (control group)
Number of subjects: 54
Study 7526468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine (Navelbine) as a single agent
Number of subjects: 0
Study 7526468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with cisplatin
Number of subjects: 0
Study 7526468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine in combination with other agents (5-fluorouracil/leucovorin, mitomycin-C, ifosfamide, carboplatin, paclitaxel)
Number of subjects: 0
Study 7526468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine and cisplatin followed by accelerated radiation
Number of subjects: 0
Study 7526468 — intervention group
Group type: EXPERIMENTAL
Intervention: Vinorelbine in small cell lung cancer
Number of subjects: 0
Study 2657057 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol
Number of subjects: 19
Study 2657057 — intervention group
Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 19
Study 2657057 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem
Number of subjects: 19
Study 2657057 — intervention group
Group type: EXPERIMENTAL
Intervention: Verapamil
Number of subjects: 19
Study 2657057 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 29676193 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidget spinners (used by 48 children during the initial phase of treatment)
Number of subjects: 60
Study 29676193 — intervention group
Group type: EXPERIMENTAL
Intervention: Fidget spinners (used by 48 children during both phases of treatment)
Number of subjects: 60
Study 31278097 — intervention group
Group type: EXPERIMENTAL
Intervention: 80 ppm nitric oxide (NO) gas
Number of subjects: 250
Study 31278097 — intervention group
Group type: COMPARATOR
Intervention: 80 ppm nitrogen (N2) gas (control group)
Number of subjects: 250
Study 28872486 — intervention group
Group type: EXPERIMENTAL
Intervention: Divalent iron (ferrous sulfate) 2 mg/kg/d for 5 months
Number of subjects: 112
Study 28872486 — intervention group
Group type: COMPARATOR
Intervention: Trivalent iron (ferric polymaltose) 2 mg/kg/d for 5 months
Number of subjects: 112
Study 28872486 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Divalent and Trivalent)
Number of subjects: 112
Study 27271310 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine (2.5-10 mg)
Number of subjects: 19
Study 27271310 — intervention group
Group type: EXPERIMENTAL
Intervention: Binder (servo-controlled venous compression at 40 mmHg)
Number of subjects: 19
Study 27271310 — intervention group
Group type: EXPERIMENTAL
Intervention: Binder
Number of subjects: 19
Study 27271310 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 19
Study 27271310 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19
Study 27271310 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of midodrine and binder
Number of subjects: 19
Study 24638033 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading in color with specially prepared books pairing letters with colors; details on dosage and duration not specified.
Number of subjects: 0
Study 24638033 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading experience questionnaire administered post-intervention; details on dosage and duration not specified.
Number of subjects: 0
Study 22479155 — intervention group
Group type: EXPERIMENTAL
Intervention: SP-AQ (sulfadoxine-pyrimethamine plus amodiaquine)
Number of subjects: 1121
Study 22479155 — intervention group
Group type: EXPERIMENTAL
Intervention: SP-AS (sulfadoxine-pyrimethamine plus artesunate)
Number of subjects: 1121
Study 22479155 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1121
Study 20807303 — intervention group
Group type: EXPERIMENTAL
Intervention: Decaffeinated green tea (960 mL daily for 6 months)
Number of subjects: 54
Study 17618081 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 Gauss magnets
Number of subjects: 40
Study 17618081 — intervention group
Group type: COMPARATOR
Intervention: 50 Gauss magnets
Number of subjects: 40
Study 17618081 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 40
Study 15883143 — intervention group
Group type: EXPERIMENTAL
Intervention: Collaborative care as part of the Multifaceted Oncology Depression Program
Number of subjects: 55
Study 15883143 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 55
Study 11887555 — intervention group
Group type: EXPERIMENTAL
Intervention: Invasive strategy (early angioplasty with coronary stents)
Number of subjects: 0
Study 11887555 — intervention group
Group type: COMPARATOR
Intervention: Conservative strategy (medical stabilization)
Number of subjects: 0
Study 9817151 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-breath (SB) method
Number of subjects: 80
Study 9817151 — intervention group
Group type: COMPARATOR
Intervention: Tidal-breathing (TB) method
Number of subjects: 80
Study 9726343 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole (15 mg/kg/day)
Number of subjects: 63
Study 9726343 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 63
Study 9726343 — intervention group
Group type: EXPERIMENTAL
Intervention: Albendazole
Number of subjects: 63
Study 1765727 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel study guides with different levels of referential cues, implemented through teacher‐directed, dyadic, and independent instructional groups.
Number of subjects: 82
Study 1765727 — intervention group
Group type: COMPARATOR
Intervention: Single‐level study guides without referential cues, implemented as an independent activity.
Number of subjects: 82
Study 1765727 — intervention group
Group type: EXPERIMENTAL
Intervention: Multilevel study guides in high school social studies.
Number of subjects: 82
Study 1765727 — intervention group
Group type: COMPARATOR
Intervention: Single‐level study guides in high school social studies.
Number of subjects: 82
Study 7123469 — intervention group
Group type: EXPERIMENTAL
Intervention: Low lint, nonwoven surgical sponge material
Number of subjects: 232
Study 7123469 — intervention group
Group type: COMPARATOR
Intervention: Cotton gauze
Number of subjects: 232
Study 30328059 — intervention group
Group type: EXPERIMENTAL
Intervention: Omeprazole
Number of subjects: 0
Study 30328059 — intervention group
Group type: COMPARATOR
Intervention: Sporanox
Number of subjects: 0
Study 27481208 — intervention group
Group type: EXPERIMENTAL
Intervention: real iTBS
Number of subjects: 17
Study 27481208 — intervention group
Group type: COMPARATOR
Intervention: sham iTBS
Number of subjects: 17
Study 27481208 — intervention group
Group type: EXPERIMENTAL
Intervention: iTBS
Number of subjects: 17
Study 24842156 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV and cytology double testing (intervention arm)
Number of subjects: 12527
Study 24842156 — intervention group
Group type: COMPARATOR
Intervention: Cytology with samples frozen for future HPV testing (control arm)
Number of subjects: 12527
Study 24842156 — intervention group
Group type: EXPERIMENTAL
Intervention: HPV positivity
Number of subjects: 12527
Study 24842156 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 16 HPV
Number of subjects: 12527
Study 24842156 — intervention group
Group type: EXPERIMENTAL
Intervention: Type 31 HPV
Number of subjects: 12527
Study 26880056 — intervention group
Group type: EXPERIMENTAL
Intervention: Carotid stenting
Number of subjects: 1710
Study 26880056 — intervention group
Group type: COMPARATOR
Intervention: Endarterectomy
Number of subjects: 1710
Study 24034580 — intervention group
Group type: EXPERIMENTAL
Intervention: Buccal placement of 400-mcg misoprostol
Number of subjects: 73
Study 24034580 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study 21788759 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral formula containing a synbiotic blend (Lactobacillus paracasei NCC 2461, Bifidobacterium longum NCC 3001, fructooligosaccharides, inulin, Acacia gum)
Number of subjects: 94
Study 21788759 — intervention group
Group type: COMPARATOR
Intervention: Control formula
Number of subjects: 94
Study 19374449 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyphenol-rich black tea consumption
Number of subjects: 0
Study 19374449 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 16733111 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-FNA
Number of subjects: 84
Study 16733111 — intervention group
Group type: COMPARATOR
Intervention: CT/US-FNA
Number of subjects: 84
Study 15304672 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA-1 cold light (12 J/cm2/day for 15 days)
Number of subjects: 12
Study 15304672 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA-1 cold light
Number of subjects: 12
Study 15304672 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 11387284 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg of mifepristone administered on day LH + 2
Number of subjects: 32
Study 11387284 — intervention group
Group type: COMPARATOR
Intervention: Control group (20 women trying to conceive)
Number of subjects: 32
Study 10402385 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG administered after endogenous LH surge (Group 2)
Number of subjects: 219
Study 10402385 — intervention group
Group type: EXPERIMENTAL
Intervention: HCG administered before endogenous LH surge (Group 3)
Number of subjects: 219
Study 10402385 — intervention group
Group type: COMPARATOR
Intervention: Endogenous LH surge without HCG (Group 1)
Number of subjects: 219
Study 10402385 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall clinical pregnancy rate across all groups
Number of subjects: 219
Study 10402385 — intervention group
Group type: EXPERIMENTAL
Intervention: Partner's semen
Number of subjects: 219
Study 10402385 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor semen
Number of subjects: 219
Study 8607570 — intervention group
Group type: EXPERIMENTAL
Intervention: Honey (30 g)
Number of subjects: 78
Study 8607570 — intervention group
Group type: COMPARATOR
Intervention: Placebo (30 g of syrup)
Number of subjects: 78
Study 2746145 — intervention group
Group type: EXPERIMENTAL
Intervention: Rangiometer
Number of subjects: 24
Study 2746145 — intervention group
Group type: COMPARATOR
Intervention: Goniometer
Number of subjects: 24
Study 321508 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftidrofuryl (Praxilene) 300 mg daily for 90 days
Number of subjects: 60
Study 321508 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study 31503275 — intervention group
Group type: EXPERIMENTAL
Intervention: Aging Back Clinics (ABC) care
Number of subjects: 55
Study 31503275 — intervention group
Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 55
Study 30697810 — intervention group
Group type: EXPERIMENTAL
Intervention: DementiAbility Methods: The Montessori Way (DMMW)
Number of subjects: 46
Study 30697810 — intervention group
Group type: COMPARATOR
Intervention: Structured social activities (Control)
Number of subjects: 46
Study 27665582 — intervention group
Group type: EXPERIMENTAL
Intervention: Coping Power Universal (intervention group)
Number of subjects: 901
Study 27665582 — intervention group
Group type: COMPARATOR
Intervention: Standard academic curriculum (control group)
Number of subjects: 901
Study 26131837 — intervention group
Group type: EXPERIMENTAL
Intervention: New EMR system
Number of subjects: 526
Study 26131837 — intervention group
Group type: COMPARATOR
Intervention: Standard EMR system
Number of subjects: 526
Study 23514667 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin
Number of subjects: 306
Study 23514667 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin + ulinastatin
Number of subjects: 306
Study 23514667 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin + S miltiorrhiza
Number of subjects: 306
Study 23514667 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatostatin + ulinastatin + S miltiorrhiza
Number of subjects: 306
Study 23514667 — intervention group
Group type: COMPARATOR
Intervention: Basic treatment
Number of subjects: 306
Study 21515118 — intervention group
Group type: EXPERIMENTAL
Intervention: Pairing condition (n=40)
Number of subjects: 78
Study 21515118 — intervention group
Group type: COMPARATOR
Intervention: Exposure-only condition (n=38)
Number of subjects: 78
Study 18758684 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone
Number of subjects: 0
Study 18758684 — intervention group
Group type: EXPERIMENTAL
Intervention: Rosiglitazone
Number of subjects: 0
Study 18758684 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 17074263 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifabutin regimen
Number of subjects: 130
Study 17074263 — intervention group
Group type: COMPARATOR
Intervention: Rifapentine regimen
Number of subjects: 130
Study 15064028 — intervention group
Group type: EXPERIMENTAL
Intervention: Day care (263 women)
Number of subjects: 395
Study 15064028 — intervention group
Group type: COMPARATOR
Intervention: Ward care (132 women)
Number of subjects: 395
Study 11511129 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to the sequence prior to performing the reaction time (RT) task
Number of subjects: 0
Study 11511129 — intervention group
Group type: COMPARATOR
Intervention: No preexposure to the sequence
Number of subjects: 0
Study 11511129 — intervention group
Group type: EXPERIMENTAL
Intervention: Variant of the SRT task for 4‐year‐olds
Number of subjects: 0
Study 9272365 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular pertussis vaccines (aP) from SmithKline Beecham (SB) or Chiron Biocine (CB)
Number of subjects: 0
Study 9272365 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-cell vaccine (wP) from Connaught
Number of subjects: 0
Study 9272365 — intervention group
Group type: COMPARATOR
Intervention: Diphtheria and tetanus toxoids (DT) vaccine only
Number of subjects: 0
Study 9272365 — intervention group
Group type: COMPARATOR
Intervention: DTwP vaccine
Number of subjects: 0
Study 9272365 — intervention group
Group type: EXPERIMENTAL
Intervention: DTaP vaccine
Number of subjects: 0
Study 9163637 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin (4 mg x kg(‐1) b.i.d.) for 12 weeks
Number of subjects: 25
Study 9163637 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 25
Study 2490824 — intervention group
Group type: EXPERIMENTAL
Intervention: Antihypertensive therapy
Number of subjects: 0
Study 2490824 — intervention group
Group type: COMPARATOR
Intervention: Mild hypertension
Number of subjects: 0
Study 2490824 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertension Detection and Follow‐up Program and Medicare ESRD Program analyses
Number of subjects: 0
Study 2490824 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood pressure effects on kidneys
Number of subjects: 0
Study 958757 — intervention group
Group type: EXPERIMENTAL
Intervention: Mailing from the Academy's local chapter
Number of subjects: 192
Study 958757 — intervention group
Group type: COMPARATOR
Intervention: Brief presentation by a local pharmaceutical representative
Number of subjects: 192
Study 31328540 — intervention group
Group type: EXPERIMENTAL
Intervention: Stability and coordination exercises (20 min) as part of an 80 min cardiac rehabilitation programme, twice a week for 12 weeks
Number of subjects: 26
Study 31328540 — intervention group
Group type: COMPARATOR
Intervention: Traditional cardiac rehabilitation programme
Number of subjects: 26
Study 30188086 — intervention group
Group type: EXPERIMENTAL
Intervention: Original Berger Scale for leprosy-related stigma
Number of subjects: 154
Study 30188086 — intervention group
Group type: EXPERIMENTAL
Intervention: New version of the SARI Stigma Scale
Number of subjects: 154
Study 25962311 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 min of propofol
Number of subjects: 72
Study 25962311 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 min of propofol
Number of subjects: 72
Study 23725523 — intervention group
Group type: EXPERIMENTAL
Intervention: Scaling and root planing (SRP) with dietary supplementation of ascorbic acid (AA) (450 mg) for two weeks
Number of subjects: 120
Study 23725523 — intervention group
Group type: COMPARATOR
Intervention: Only SRP
Number of subjects: 120